A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/08 (2006.01) A61K 38/00 (2006.01) A61K 38/04 (2006.01) A61P 1/18 (2006.01) C07K 7/06 (2006.01) C07K 7/18 (2006.01)
Patent
CA 2085781
The invention relates to the use of bradykinin-antagonists of the formula R1 - A - B - C - E - F - G - J - K - R2 wherein R1 represents hydrogen, C1-C4-alkanoyl which can be substituted by mercapto, hydroxyphenyl, (4-benzoyl)phenoxy or represents (4-benzoyl)benzoyl- Lys; A represents D-Arg or D-Lys or stands for a direct bond; B represents Arg which can be substituted by NO2 or toluol-4-sulfonyl or represents Lys which can be substituted by toluol-4-sulfonyl or CO-NH-C8H5, or stands for a direct bond; C represents Hyp- Pro-Gly, Pro-Hyp-Gly, Pro-Pro-Gly or dehydroPro-Hyp-Gly; E represents Thi, Phe, Leu or Cha; F represents Ser or Cys; G represents D-Tic, D-Phe or D-Hyp substituted by C1-C4-alkoxy; J represents Tic, Aoc or Oic; K represents Arg or Ahx or stands for a direct bond; R2 is hydroxy or amino; and the physiologically tolerable salts thereof for the treatments of acute pancreatitis, to pharmaceutical agents containing them and to the use thereof for the preparation of appropriate pharmaceutical compositions.
Griesbacher Thomas
Lembeck Fred
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
LandOfFree
Bradykinin-antagonists for the treatment of acute pancreatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bradykinin-antagonists for the treatment of acute pancreatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin-antagonists for the treatment of acute pancreatitis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1970277